FDA Approved, HIV Confirmatory Test           WHAT'S NEW            

Sanochemia´s Fluorognost IFA™ HIV-1  is the result of dedicated research and development  since 1985.  The US Food and Drug Administration (FDA) approved the assay in February 1992.  Previously known as Waldheim IFA, Fluorognost IFA confirmatory test for HIV-1 allows laboratories to establish a definite status for samples that are positive or indeterminate by routine screening assays as a PRIMARY CONFIRMATION TEST for HIV-1 instead of western blot.  Serum, plasma and dried blood spot (DBS)* eluates are all suitable substrates for testing. The assay is completed in 90 minutes, requires minimal amounts of sample, and provides an extremely high degree of accuracy.   Fluorognost HIV-1 IFA is currently being used by many Public Health Laboratories, Blood Banks, Commercial Reference Laboratories and other labs performing HIV-1 testing in the US and Europe.

NOW 2 Year dating and Concentrated Liquid Buffer (FDA cleared)

HIV WB "UNREADABLES" Paper  -  Blood Systems

MSDS SHEET

Package inserts and technical information on Fluorognost HIV-1

HIV Rapid Testing: APHL and CDC recommendations

Fluorognost HIV-1 IFA Training Seminar

Fluorognost Poster from APHL Mtg March 2003

Recommended Web Sites      

*Home Access system testing

This site was last updated  03/27/2008                                                                                                                                                                                   disclaimer